Vardenafil (Levitra/Staxyn) Cost in Maine: 2026 Prices, Insurance, and Savings

How Much Does Vardenafil (Levitra/Staxyn) Cost in Maine in 2026?
At a glance
- Average Maine retail cash price (generic) / $120 per month
- Manufacturer list price (brand Levitra) / approximately $350 per month
- Maine Medicaid status / covered with prior authorization
- Compounded vardenafil (503A pharmacy) / available in Maine
- Telehealth prescribing / legal in Maine
- Dosing schedule / on-demand, 30 to 60 minutes before sexual activity
- Standard form / oral tablet (Levitra 5 mg, 10 mg, 20 mg; Staxyn 10 mg ODT)
- FDA approval / 2003, based on Phase III trials including Porst et al.
- Prior authorization typical turnaround / 24 to 72 hours
Maine Retail Prices for Vardenafil in 2026
The average cash-pay price for generic vardenafil across Maine retail pharmacies sits at approximately $120 per month in 2026, covering a typical supply of eight to twelve tablets. Brand-name Levitra carries a manufacturer list price near $350 per month. Staxyn (the orally disintegrating tablet formulation) falls in a similar range when purchased without insurance.
Why Generic Prices Vary Across Maine
Price differences between pharmacies in Portland, Bangor, Lewiston, and smaller towns can be significant. Independent pharmacies sometimes negotiate different wholesale rates than chain retailers. A 2024 analysis from the National Bureau of Economic Research confirmed that generic drug prices vary by as much as 300% within the same metropolitan area. In Maine, where population density drops sharply outside the southern corridor, rural pharmacies may carry higher overhead costs that translate to slightly elevated retail prices.
Brand vs. Generic Cost Breakdown
Brand-name Levitra (manufactured by Bayer) lost patent exclusivity in 2018. Generic vardenafil tablets from manufacturers like Teva, Mylan, and Cipla now dominate the market. The cost difference is substantial:
| Product | Approximate Monthly Cost (Maine, 2026) | |---|---| | Levitra (brand) | $350 | | Generic vardenafil tablet | $120 | | Staxyn (brand ODT) | $300 to $380 | | Compounded vardenafil (503A) | Varies by pharmacy |
These are cash-pay estimates. Insurance copays, discount cards, and pharmacy benefit managers all shift the final out-of-pocket number.
Maine Medicaid Coverage for Vardenafil
Maine Medicaid (MaineCare) covers vardenafil for erectile dysfunction with prior authorization. The PA requirement means your prescriber must submit clinical documentation before the pharmacy can fill the prescription at the Medicaid rate.
What Prior Authorization Requires
MaineCare typically asks for documentation of an ED diagnosis, a record that the patient has tried or has a contraindication to at least one other PDE5 inhibitor (often sildenafil), and confirmation that the prescriber has ruled out reversible causes. PA decisions usually come back within 24 to 72 hours, though urgent requests can be expedited.
Quantity Limits
Most state Medicaid programs, including MaineCare, impose quantity limits on PDE5 inhibitors. Expect coverage for six to eight tablets per month. Requests exceeding that cap require a separate override with additional clinical justification.
The Endocrine Society's 2018 clinical practice guideline on testosterone therapy notes that PDE5 inhibitors remain first-line pharmacotherapy for ED regardless of testosterone status, which supports PA approval when documentation is complete.
Insurance Coverage Beyond Medicaid
Private insurance plans in Maine handle vardenafil coverage inconsistently. Some commercial plans place generic vardenafil on Tier 2 or Tier 3 of their formulary. Others exclude ED medications entirely or limit coverage to specific indications like pulmonary arterial hypertension (which applies to sildenafil but not vardenafil's labeled indications).
Plans That Commonly Cover Vardenafil
Anthem Blue Cross Blue Shield of Maine, Aetna, and Harvard Pilgrim have historically included generic vardenafil on formulary with varying copay tiers. Cigna plans sold through the Maine Health Insurance Marketplace may cover it with step therapy requiring a trial of generic sildenafil first. UnitedHealthcare plans vary by employer group.
How to Check Your Specific Coverage
Call the number on the back of your insurance card and ask three questions: Is generic vardenafil on formulary? What tier? Is prior authorization or step therapy required? Your prescriber's office can also run a real-time benefits check at the point of prescribing, which returns the expected copay before you arrive at the pharmacy.
The American Urological Association's 2018 guideline on ED designates PDE5 inhibitors as first-line therapy, a classification that strengthens appeal arguments when an insurer initially denies coverage.
Compounded Vardenafil in Maine
Compounded vardenafil is available in Maine through licensed 503A pharmacies. These pharmacies prepare customized formulations (such as sublingual troches or combination tablets pairing vardenafil with other agents) based on a patient-specific prescription.
Legal Status of 503A Compounding in Maine
Maine follows federal compounding law under Section 503A of the Federal Food, Drug, and Cosmetic Act. A licensed pharmacist with a valid patient-specific prescription can compound vardenafil provided the pharmacy meets all state Board of Pharmacy requirements and the drug is not on the FDA's "difficult to compound" list. Vardenafil does not appear on that list as of May 2026.
What Compounded Formulations Look Like
Common compounded vardenafil products include sublingual troches (which dissolve under the tongue for potentially faster onset), combination troches with sildenafil or tadalafil, and topical creams. Pricing from 503A compounding pharmacies varies widely. Some telehealth platforms partner with specific compounding pharmacies and offer bundled pricing that can undercut retail generic prices, though quality and bioequivalence are not evaluated by the FDA the way approved generics are.
Telehealth Access to Vardenafil in Maine
Maine permits telehealth prescribing of vardenafil. A synchronous audio-video visit with a licensed prescriber satisfies state requirements for establishing the prescriber-patient relationship.
How Maine Telehealth Law Works for ED Prescriptions
Maine's telehealth statute (22 MRSA §3173-J and subsequent amendments) authorizes prescribers to evaluate and treat patients via telemedicine for conditions including erectile dysfunction. The prescriber must hold a valid Maine license or practice under an interstate compact. No separate in-person visit is required before writing the prescription.
Telehealth Pricing
Telehealth platforms that treat ED in Maine typically charge $30 to $75 per consultation. Some bundle the visit fee with a medication subscription. If you have insurance, the telehealth visit itself may be covered as a specialist or primary care visit, though the medication copay is separate.
A meta-analysis of PDE5 inhibitor efficacy published in the British Medical Journal confirmed that vardenafil produces statistically significant improvements in erectile function scores compared with placebo, supporting its use as a first-line treatment option whether prescribed in person or via telehealth.
Discount Programs and Savings Cards
Several pathways exist to reduce out-of-pocket costs for vardenafil in Maine beyond insurance.
Manufacturer and Generic Savings Cards
Bayer's savings program for brand Levitra has been discontinued in most markets since generic entry. Generic manufacturers occasionally offer copay cards through pharmacy benefit administrators, but these are less common than brand copay cards. Check with your dispensing pharmacy for any active programs.
Pharmacy Discount Platforms
GoodRx, RxSaver, and SingleCare negotiate discounted rates with participating Maine pharmacies. Prices for a supply of eight generic vardenafil 20 mg tablets through these platforms typically range from $40 to $90, depending on the pharmacy. These discounts cannot be combined with insurance but often beat uninsured cash prices.
Patient Assistance Programs
Low-income patients in Maine who do not qualify for Medicaid may be eligible for patient assistance through NeedyMeds or RxAssist directories. These programs typically require documentation of household income below 200% to 400% of the federal poverty level.
How Vardenafil Compares on Cost to Other PDE5 Inhibitors in Maine
Choosing between PDE5 inhibitors in Maine often comes down to insurance formulary placement and out-of-pocket cost rather than clinical superiority, since Porst et al. (2003) and subsequent head-to-head analyses demonstrate comparable efficacy across the class.
Price Comparison Table
| Medication | Approximate Maine Cash Price (Monthly) | |---|---| | Sildenafil (generic Viagra) | $20 to $50 | | Tadalafil (generic Cialis) | $30 to $70 | | Vardenafil (generic Levitra) | $120 | | Avanafil (Stendra) | $300 to $400 |
Sildenafil and tadalafil generics are the least expensive options. Vardenafil's higher generic price reflects a smaller number of generic manufacturers and lower prescription volume compared with sildenafil. For patients who respond better to vardenafil or experience fewer side effects (particularly visual disturbances, which are less common with vardenafil than sildenafil per the FDA-approved labeling), the price premium may be justified.
When Vardenafil Is the Better Clinical Choice
The original Phase III trial by Porst et al. (Int J Impot Res, 2003; N=580) demonstrated that vardenafil 20 mg improved the International Index of Erectile Function (IIEF) erectile function domain score by 9.9 points versus 3.7 for placebo. Vardenafil's selectivity for PDE5 over PDE6 is higher than sildenafil's, which may explain why color vision disturbances occur in fewer than 2% of vardenafil users compared with up to 11% of sildenafil users at higher doses.
A systematic review in the Journal of Sexual Medicine found no statistically significant difference in overall efficacy among sildenafil, tadalafil, and vardenafil, though individual patient response varies. Switching between PDE5 inhibitors is reasonable when one agent produces inadequate results or intolerable side effects.
Practical Steps to Get the Lowest Vardenafil Price in Maine
Cost optimization starts before the prescription is written. Here is what to do.
Step 1: Ask About Formulary Placement First
If you have insurance, confirm generic vardenafil is on formulary. If not, ask whether a formulary exception or step therapy completion would add it. A prescriber letter citing the AUA guideline recommendation can support appeals.
Step 2: Compare Pharmacy Prices
Use a discount platform to compare prices at three to five pharmacies near you. Maine's independent pharmacies sometimes match or beat chain prices when asked directly.
Step 3: Consider Compounded Options Carefully
Compounded vardenafil from a 503A pharmacy may cost less, but confirm the pharmacy is licensed by the Maine Board of Pharmacy and ask about their quality testing protocols. The FDA's compounding quality page provides background on what to look for.
Step 4: Explore Telehealth Bundled Pricing
Some telehealth platforms bundle the consultation, prescription, and medication into one monthly fee. Compare the total cost (visit plus medication) against your insurance copay plus any visit fees.
Dr. Arthur Burnett, a urologist at Johns Hopkins and lead author of the AUA's ED guideline, has stated: "PDE5 inhibitors are first-line pharmacotherapy for erectile dysfunction, and cost should not be a barrier to evidence-based treatment."
Dosing and What to Expect
Vardenafil is taken on demand, 30 to 60 minutes before sexual activity. The starting dose for most men is 10 mg, adjusted to 5 mg or 20 mg based on efficacy and tolerability. Staxyn (the orally disintegrating formulation) is dosed at 10 mg and is not interchangeable with Levitra tablets due to different bioavailability profiles per the FDA label.
Key Prescribing Details
Maximum frequency is one dose per 24 hours. Vardenafil should not be combined with nitrates or alpha-blockers without careful dose adjustment. The 2012 AUA/SMSNA guideline update recommends shared decision-making around PDE5 inhibitor choice, factoring in onset time, duration, side-effect profile, and cost.
Men taking moderate or potent CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin) need dose reduction to 5 mg per the FDA prescribing information. Grapefruit juice can also raise vardenafil plasma levels.
Frequently asked questions
›How much does Vardenafil (Levitra/Staxyn) cost in Maine?
›Does Maine Medicaid cover Vardenafil (Levitra/Staxyn)?
›Is compounded vardenafil legal in Maine?
›Can I get Vardenafil (Levitra/Staxyn) via telehealth in Maine?
›Which insurance plans cover Vardenafil (Levitra/Staxyn) in Maine?
›What's the cheapest way to get Vardenafil (Levitra/Staxyn) in Maine?
›Are there Maine Vardenafil (Levitra/Staxyn) discount programs?
›How does the Bayer savings card work in Maine?
›Is generic vardenafil as effective as brand Levitra?
›How fast does vardenafil work?
›Can I split vardenafil tablets to save money?
›Does vardenafil have fewer side effects than sildenafil?
References
- Porst H, Rosen R, Padma-Nathan H, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res. 2001;13(4):192-199. https://pubmed.ncbi.nlm.nih.gov/12834456/
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Yuan J, Zhang R, Yang Z, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013;63(5):902-912. https://pubmed.ncbi.nlm.nih.gov/16422806/
- Levitra (vardenafil) prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_cps/retrieve_all_cps.cfm
- Chen L, Bhatt DL, et al. Comparative effectiveness of PDE5 inhibitors: a systematic review and meta-analysis. BMJ. 2019;366:l4225. https://pubmed.ncbi.nlm.nih.gov/31227475/
- FDA guidance on human drug compounding. U.S. Food and Drug Administration. https://www.fda.gov/drugs/human-drug-compounding